Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2018, Article ID 5301631, 5 pages
https://doi.org/10.1155/2018/5301631
Research Article

No Relation between Psoriasis and Renal Abnormalities: A Case-Control Study

1Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2Internal Medicines Ward, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Correspondence should be addressed to Nikoo Mozafari; moc.oohay@dm_ookin

Received 7 December 2017; Accepted 9 January 2018; Published 11 February 2018

Academic Editor: Allen R. Nissenson

Copyright © 2018 Zohreh Tehranchinia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U. Mrowietz, K. Kragballe, K. Reich et al., “Definition of treatment goals for moderate to severe psoriasis: A European consensus,” Archives of Dermatological Research, vol. 303, no. 1, pp. 1–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. P. L. Mattei, K. C. Corey, and A. B. Kimball, “Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies,” Journal of the European Academy of Dermatology and Venereology, vol. 28, pp. 333–337, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. V. Duarte, M. D. F. S. P. de Oliveira, I. Follador, T. S. Silva, and E. M. D. C. Filho, “Diagnosis and underdiagnosis of comorbidities in psoriasis patients -need for a multidisciplinary approach,” Anais Brasileiros de Dermatologia, vol. 91, no. 6, pp. 743–747, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Sales and T. Torres, “Psoriasis and metabolic syndrome,” Acta Dermatovenerologica Croatica (ADC), vol. 22, no. 3, pp. 169–174, 2014. View at Google Scholar · View at Scopus
  5. J. Wan, S. Wang, K. Haynes, M. R. Denburg, D. B. Shin, and J. M. Gelfand, “Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study,” British Medical Journal, vol. 347, Article ID f5961, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Visconti, G. Leonardi, M. Buemi et al., “Kidney disease and psoriasis: novel evidences beyond old concepts,” Clinical Rheumatology, vol. 35, no. 2, pp. 297–302, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. J. C. Szepietowski, E. Bielicka, F. Wasik, W. Kopec, and T. Szepietowski, “Microalbuminuria as a subclinical marker of renal impairment in subjects with psoriasis vulgaris,” Journal of the European Academy of Dermatology and Venereology, vol. 14, no. 6, pp. 513-514, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Cecchi, G. Seghieri, A. Gironi, F. Tuci, and A. Giomi, “Relation between urinary albumin excretion and skin involvement in patients with psoriasis,” Dermatology, vol. 185, no. 2, pp. 93–95, 1992. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Cassano, M. Vestita, M. Panaro, M. Carbonara, and G. A. Vena, “Renal function in psoriasis patients,” European Journal of Dermatology, vol. 21, no. 2, pp. 264-265, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Dervisoglu, A. S. Akturk, K. Yildiz, R. Kiran, and A. Yilmaz, “The spectrum of renal abnormalities in patients with psoriasis,” International Urology and Nephrology, vol. 44, no. 2, pp. 509–514, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Kaftan, B. Kaftan, M. F. Toppare, and M. Eksioglu, “Renal involvement in psoriasis,” Dermatology, vol. 192, no. 2, pp. 189-190, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Y. Chiu, H. L. Huang, C. H. Li et al., “Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study,” British Journal of Dermatology, vol. 173, no. 1, pp. 146–154, 2015. View at Publisher · View at Google Scholar
  13. A. Khan, I. Haider, M. Ayub, and M. Humayun, “Psoriatic Arthritis Is an Indicator of Significant Renal Damage in Patients with Psoriasis: An Observational and Epidemiological Study,” International Journal of Inflammation, vol. 2017, Article ID 5217687, 2017. View at Publisher · View at Google Scholar · View at Scopus
  14. D. J. Pearce, A. E. Morrison, K. B. Higgins et al., “The comorbid state of psoriasis patients in a university dermatology practice,” Journal of Dermatological Treatment, vol. 16, no. 5-6, pp. 319–323, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Yeung, J. Takeshita, N. N. Mehta et al., “Psoriasis severity and the prevalence of major medical comorbidity: a population-based study,” JAMA Dermatology, vol. 149, no. 10, pp. 1173–1179, 2013. View at Publisher · View at Google Scholar · View at Scopus